ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2932

HLA-DR3 Restricted Response to Lupus-Related Auto-Antigen Smd: Autoreactive T Cells Are Inherent in Normal Immune Repertoires

Zhenhuan Zhao1, Jiling Ren1, Chao Dai2, Carol Kannapell1, Qian Wang3, Felicia Gaskin4 and Shu Man Fu5, 1Medicine/CIIR/Rheumatology, University of Virginia, Charlottesville, VA, 2Center for Immunity, Inflammation, and Regenerative Medicine, University of Virginia, Charlottesville, VA, 3University of Virginia, Charlottesville, VA, 4Psychiatry and Neurobehavioral Sciences, University of Virginia, Charlottesville, VA, 5Department of Medicine, University of Virginia, Charlottesville, VA

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: autoantibodies and autoantigens, Lupus, T cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 15, 2016

Title: T Cell Biology and Targets in Autoimmune Disease - Poster Session II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: HLA class II is the major susceptibility region for systemic lupus erythematosus (SLE) and other autoimmune disorders such as rheumatoid arthritis, multiple sclerosis and type 1 diabetes. The current paradigm is that autoimmune response is the result of breaking tolerance. However, it’s difficult to explain the presence of autoreactive Abs and T cells in normal people. Previously we showed HLA-DR3 (DR3) transgenic mice respond best to immunization with SmD and Ro60. To clarify the mechanisms for auto-Ab generation to SLE-related Ags, we undertook a detailed analysis of the anti-SmD T cell responses in DR3+AE0 mice.

Methods: T-T hybridomas were generated by fusing lymph node cells from DR3+AE0 mice immunized with SmD in IFA with BW5147TCR-/-. IL-2 in the supernatants of T-T hybridomas stimulated by SmD with syngeneic splenic cells as APC was determined by ELISA. SmD T cell epitope regions were determined with 15mers overlapping by 3 amino acids covering the span of SmD with the established T-T hybridomas. The core epitopes were determined by alanine substitutions. TCR utilized by T-T hybridomas were sequenced. For response to SmD peptides and its mimics DR3+AE0 mice were immunized with 100µg peptide in CFA on day 1 and 50 µg of the immunogen in IFA on days 14 and 28. Sera were collected at 42, 56, 70, 90 and 120 days and assayed for Abs to SLE-related auto-Ags. Two hundred blood samples of healthy donors from Virginia Blood Services were analyzed for their HLA-DR types and auto-Abs titers.  

Results: 47 stable T-T hybridomas reactive to SmD were generated by 7 fusions. They reacted with seven SmD antigenic regions. By alanine substitutions, they reacted with varied core epitopes. In some, the flanking sequences contributed to the core epitopes. The TCR of 17 hybridomas were sequenced. They used unique combinations of TCRα and TCRβ. By bioinformatics, we identified more than 10,000 potential bacterial peptide mimics of SmD T cell epitopes. Some of them are from commensal bacteria residing in the mucosal surfaces and skin. The ranking of affinities for SmD T epitopes to DR3 were in the mid-ranges among those of all potential bacterial mimics. 12 bacterial mimics from one of the SmD T epitopes with high, medium, and low affinities for DR3 were selected. Only those with modest binding affinities were able to stimulate relevant hybridomas and to induce auto-Ab in a similar fashion as the corresponding SmD peptide. The 200 blood donors were typed for HLA-DR2, DR3 and DR4. DR3+ individuals had higher anti-SmD Abs than those who were negative for DR3 and DR2.  

Conclusion: SmD has multiple T cell epitopes and the immune response to SmD is similar of those to conventional Ags with diverse TCRs. The T cells with cross-reactivity to auto-epitopes and to bacterial mimics are those with moderate binding affinities to the relevant DR molecules. They are likely to be positively selective for the purpose of host defense against pathogens. This thesis is supported by the finding of auto-Abs with high titers to SLE-related auto-Ags. These results provide us insight into the origin of SLE-related auto-Abs. On a basic level, they support the thesis that auto-reactive T cells are an inherent part of the normal immune repertoire.


Disclosure: Z. Zhao, None; J. Ren, None; C. Dai, None; C. Kannapell, None; Q. Wang, None; F. Gaskin, None; S. M. Fu, None.

To cite this abstract in AMA style:

Zhao Z, Ren J, Dai C, Kannapell C, Wang Q, Gaskin F, Fu SM. HLA-DR3 Restricted Response to Lupus-Related Auto-Antigen Smd: Autoreactive T Cells Are Inherent in Normal Immune Repertoires [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/hla-dr3-restricted-response-to-lupus-related-auto-antigen-smd-autoreactive-t-cells-are-inherent-in-normal-immune-repertoires/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/hla-dr3-restricted-response-to-lupus-related-auto-antigen-smd-autoreactive-t-cells-are-inherent-in-normal-immune-repertoires/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology